Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updates Home of: - touchONCOLOGY - touchENDOCRINOLOGY - touchOPHTHALMOLOGY - touchNEUROLOGY - touchCARDIOLOGY - touchINFECTIOUSDISEASES - touchIMMUNOLOGY - touchRESPIRATORY - touchHAEMATOLOGY - touchDERMATOLOGY This information is intended for use by licensed Healthcare Professionals (HCPs). It should not be considered medical advice, diagnosis, or treatment recommendations.
Episodes
Wednesday Feb 21, 2024
Emerging second-line treatment approaches in advanced NSCLC: The role of ADCs
Wednesday Feb 21, 2024
Wednesday Feb 21, 2024
touchTALKS for touchRESPIRATORY
Listen to a leading expert in lung cancer discuss the role of antibody–drug conjugates (ADCs) in the treatment of patients with advanced non-small cell lung cancer, including their structure and mechanistic rationale, the latest clinical trial data and the optimal management of patients receiving ADCs.
The expert
- Dr Rebecca Heist – Massachusetts General Hospital, Boston, MA, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from AstraZeneca and is jointly provided by USF Health and touchIME.
For further information visit our website: touchrespiratory.com
Wednesday Feb 14, 2024
Addressing the diagnosis and management of pet allergies in primary care and beyond
Wednesday Feb 14, 2024
Wednesday Feb 14, 2024
touchFOCUS for touchRESPIRATORY
Dr Ann-Marie Schoos answers a series of questions on the diagnosis and management of pet allergies, including the role of component-resolved diagnostics in providing a detailed analysis of patients' sensitization profiles to allow for a more personalized approach to management.
The expert:
- Dr Ann-Marie Schoos - University of Copenhagen, Denmark
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Thermo Fisher Scientific. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchimmunology.com
Friday Feb 09, 2024
Friday Feb 09, 2024
touchFOCUS for touchIMMUNOLOGY
Dr Ann-Marie Schoos answers a series of questions on the diagnosis and management of pet allergies, including the role of component-resolved diagnostics in providing a detailed analysis of patients' sensitization profiles to allow for a more personalized approach to management.
The expert:
- Dr Ann-Marie Schoos - University of Copenhagen, Denmark
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Thermo Fisher Scientific. This activity is jointly provided by USF Health and touchIME.
For further information visit our website: www.touchimmunology.com
Friday Feb 09, 2024
Friday Feb 09, 2024
touchEXPERT OPINIONS for touchHAEMATOLOGY
Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigational agents.
The experts
- Prof. Cristina Gasparetto - Duke Cancer Institute, Durham, NC, USA
- Prof. Sagar Lonial - Emory University, Atlanta, GA, USA
- Prof. Sundar Jagannath - Tisch Cancer Institute, New York, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchhaematologyime.org/eo-in-rrmm
Friday Feb 09, 2024
Friday Feb 09, 2024
touchEXPERT OPINIONS for touchONCOLOGY
Three internationally renowned multiple myeloma experts share insights into the unmet treatment needs for patients with relapsed/refractory multiple myeloma, the rationale for emerging protein degradation and immunomodulation-based therapies, and the latest data and ongoing clinical trials for these investigational agents.
The experts
- Prof. Cristina Gasparetto - Duke Cancer Institute, Durham, NC, USA
- Prof. Sagar Lonial - Emory University, Atlanta, GA, USA
- Prof. Sundar Jagannath - Tisch Cancer Institute, New York, NY, USA
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://touchoncologyime.org/eo-in-rrmm
Wednesday Feb 07, 2024
touchIMMUNOLOGY - Diagnosing and treating patients with EoE: Tackling the difficulties
Wednesday Feb 07, 2024
Wednesday Feb 07, 2024
touchEXPERT OPINIONS for touchIMMUNOLOGY
Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care.
The experts:
- Dr Efrem Eren, Southampton General Hospital, UK
- Dr Nirmala Gonsalves, Northwestern University Feinberg School of Medicine, Chicago, USA
- Dr Jamal Hayat, St George's University Hospitals NHS Trust, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME.
For further information visit: https://touchimmunology.org/eoe-diagnosis-treatment
Wednesday Feb 07, 2024
touchRESPIRATORY - Diagnosing and treating patients with EoE: Tackling the difficulties
Wednesday Feb 07, 2024
Wednesday Feb 07, 2024
touchEXPERT OPINIONS for touchRESPIRATORY
Three experts discuss the challenges related to recognizing, diagnosing and treating patients with eosinophilic oesophagitis (EoE) and highlight how advances in diagnostic tools and emerging treatments may impact future care.
The experts:
- Dr Efrem Eren, Southampton General Hospital, UK
- Dr Nirmala Gonsalves, Northwestern University Feinberg School of Medicine, Chicago, USA
- Dr Jamal Hayat, St George's University Hospitals NHS Trust, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an independent medical education grant from Sanofi and Regeneron Pharmaceuticals and is jointly provided by USF Health and touchIME.
For further information visit: https://touchrespiratoryime.org/eoe-diagnosis-treatment
Tuesday Feb 06, 2024
touchMDT – Patient-centric care for prurigo nodularis – Discussion 3
Tuesday Feb 06, 2024
Tuesday Feb 06, 2024
touchMDT for touchIMMUNOLOGY
Listen to expert and patient perspectives on the importance of a holistic, multidisciplinary approach in establishing optimal treatment and care pathways for patients with prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
- Patient advocate: Ms Sailaja Maganti, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/
Tuesday Feb 06, 2024
touchMDT – Management of prurigo nodularis – Discussion 2
Tuesday Feb 06, 2024
Tuesday Feb 06, 2024
touchMDT for touchIMMUNOLOGY
Listen to expert perspectives on the current and emerging treatment landscape for prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/
Tuesday Feb 06, 2024
touchMDT – Burden of prurigo nodularis – Discussion 1
Tuesday Feb 06, 2024
Tuesday Feb 06, 2024
touchMDT for touchIMMUNOLOGY
Listen to expert and patient perspectives on the burden and unmet clinical needs associated with prurigo nodularis.
The multidisciplinary team
- Dermatologist: Prof. Martin Mertz, Berlin, Germany
- Dermatologist: Dr Manuel Pereira, Berlin, Germany
- Psychodermatologist: Prof. Anthony Bewley, London, UK
- Patient advocate: Ms Sailaja Maganti, London, UK
This touchPODCAST is for HCPs only.
This activity is funded by an unrestricted independent medical educational grant from Sanofi and Regeneron Pharmaceuticals. This activity is jointly provided by USF Health and touchIME.
For further information visit our website:
https://www.touchimmunology.com/cme/mdt-patient-centric-care-prurigo-nodularis/